Related Experiment Videos
[Children of mothers with phenylketonuria (author's transl)]
Insights
Maternal phenylketonuria can cause severe developmental issues in children, including microcephaly and intellectual disability. Strict dietary management during pregnancy is crucial for preventing these adverse outcomes.
Area of Science:
- Medical Genetics
- Developmental Biology
- Metabolic Disorders
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder requiring dietary management.
- Maternal PKU, if untreated during pregnancy, poses significant risks to fetal development.
- The increasing number of women with PKU reaching reproductive age highlights the importance of maternal PKU management.
Observation:
- Two children born to an untreated mother with PKU exhibited microcephaly and severe motor/mental retardation.
- Published data reveal high rates of microcephaly (39/72), intrauterine growth retardation (33/72), and neurological deficits (25/72) in offspring exposed to high maternal phenylalanine levels (>200 mg/L).
Findings:
- Maternal metabolic dysfunction in PKU directly correlates with adverse neurodevelopmental outcomes in offspring.
- High maternal phenylalanine levels during gestation are teratogenic, leading to congenital abnormalities and cognitive impairment.
- Successful pregnancy outcomes with normal development are achievable with strict adherence to a phenylalanine-restricted diet during gestation.
Implications:
- Emphasizes the critical need for preconception counseling and strict dietary control for women with PKU planning pregnancy.
- Highlights the teratogenic potential of uncontrolled maternal hyperphenylalaninemia.
- Suggests that proactive management of maternal PKU can prevent severe birth defects and ensure normal offspring development.
Abstract:
Microcephaly and considerable motor and mental retardation occurred in two non-phenylketonuric children of an untreated mother with phenylketonuria. The cerebral damage of the children must be considered the consequence of the maternal metabolic disorder. Since the first phenylketonuric children who were treated on strict diet are now reaching the age of marriage and pregnancy, the problem of maternal phenylketonuria is becoming topical. Published reports indicate that of 72 well documented cases with a maternal phenylalanine level above 200 mg/1 (1210 mumol/1) 39 offspring had microcephaly, in 33 intra-uterine growth had been retarded and in 25 there are cerebral palsy and seizures. Almost all had mental retardation. At the same time there have been reports about three normal children whose mothers had kept to a phenylalanine-low diet during their pregnancy.